VOYA Investment Management
ADMA icon

VOYA Investment Management’s ADMA Biologics ADMA Stock Holding History

VOYA Investment Management’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$610K Sell
72,877
-16,918
-19% -$154K ﹤0.01% 1724
2026
Q1 		$809K Sell
89,795
-1,922,301
-96% -$30.3M ﹤0.01% 1526
2025
Q4 		$36.7M Buy
2,012,096
+557,946
+38% +$9.4M 0.04% 364
2025
Q3 		$21.3M Buy
1,454,150
+55,244
+4% +$947K 0.02% 484
2025
Q2 		$25.5M Buy
1,398,906
+524,303
+60% +$10.7M 0.03% 463
2025
Q1 		$17.4M Sell
874,603
-43,758
-5% -$757K 0.02% 568
2024
Q4 		$15.7M Buy
918,361
+292,642
+47% +$5.51M 0.02% 617
2024
Q3 		$12.5M Buy
625,719
+83,477
+15% +$1.3M 0.01% 697
2024
Q2 		$6.06M Buy
542,242
+471,080
+662% +$3.95M 0.01% 910
2024
Q1 		$470K Sell
71,162
-15,333
-18% -$83.8K ﹤0.01% 2043
2023
Q4 		$391K Buy
86,495
+1,056
+1% +$3.91K ﹤0.01% 2203
2023
Q3 		$306K Buy
85,439
+1,474
+2% +$5.67K ﹤0.01% 2297
2023
Q2 		$310K Buy
83,965
+12,652
+18% +$46.9K ﹤0.01% 2346
2023
Q1 		$236K Hold
71,313
– – ﹤0.01% 2442
2022
Q4 		$277K Hold
71,313
– – ﹤0.01% 2384
2022
Q3 		$173K Hold
71,313
– – ﹤0.01% 2647
2022
Q2 		$141K Buy
+71,313
New +$140K ﹤0.01% 2528
2021
Q2 		– Sell
-29,207
Closed -$51K – 2803
2021
Q1 		$51K Hold
29,207
– – ﹤0.01% 2743
2020
Q4 		$57K Buy
29,207
+4,894
+20% +$10.3K ﹤0.01% 2644
2020
Q3 		$58K Hold
24,313
– – ﹤0.01% 2418
2020
Q2 		$71K Sell
24,313
-9,523
-28% -$27.4K ﹤0.01% 2388
2020
Q1 		$97K Buy
33,836
+7,807
+30% +$27K ﹤0.01% 2352
2019
Q4 		$104K Buy
26,029
+7,341
+39% +$32K ﹤0.01% 2537
2019
Q3 		$83K Buy
18,688
+7,038
+60% +$29.4K ﹤0.01% 2440
2019
Q2 		$45K Buy
+11,650
New +$51.4K ﹤0.01% 2568

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

VOYA Investment Management's ADMA Position: Q2 2026 in Review

VOYA Investment Management reduced its ADMA Biologics (ADMA) stake by 19% in Q2 2026, selling an estimated $154K and leaving 72,877 shares worth $610K. The position accounts for ﹤0.01% of the portfolio, ranked #1724.

VOYA Investment Management first reported a position in ADMA in Q2 2019 and has held it in 25 quarters since. The position peaked at $36.7M in Q4 2025. 323 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • VOYA Investment Management held 72,877 shares of ADMA Biologics worth $610K as of Q2 2026.
  • VOYA Investment Management sold 16,918 ADMA Biologics shares in Q2 2026, an estimated $154K.
  • ADMA Biologics made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #1724 holding.
  • VOYA Investment Management first reported a position in ADMA Biologics in Q2 2019 and has held it in 25 quarters since.
  • VOYA Investment Management's ADMA Biologics position peaked at $36.7M in Q4 2025.
  • 323 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.